Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients

Background Hypercoagulability is a well-known mechanism of injury in patients with COVID-19 (Rico-Mesa et al Cardiology 2020). There are several clinical reports suggesting higher incidence of venous as well as arterial thromboembolism in the infected individuals. Patients with evidence of thromboem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashraf, Farah, Mazloom, Anita, Nimkar, Neil, Patel, Nisha, Kalsi, Amardeep, Singh, Angelica, Paul, Sonal, Vishnuvardhan, Nivetha, Ashfaq, Abeer, Usta, Soeb, Kodama, Rich, Kumarasinghe, Chathula, Gregos, Peter, Weingarten, Jeremy, Khan, Uqba, Patel, Eshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
332.Anticoagulation and Antithrombotic Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330367/
http://dx.doi.org/10.1182/blood-2020-137282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330367/
http://dx.doi.org/10.1182/blood-2020-137282

Ejemplares similares